Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China · Delayed Price · Currency is CNY 48.15
-0.56 (-1.15%)
May 20, 2026, 11:34 AM CST
Betta Pharmaceuticals Market Cap
Betta Pharmaceuticals has a market cap or net worth of 20.49 billion as of May 19, 2026. Its market cap has decreased by -4.31% in one year.
Market Cap
20.49B
Enterprise Value
22.61B
Revenue
3.73B
Ranking
n/a
PE Ratio
46.30
Stock Price
48.15
Market Cap Chart
Since November 7, 2016, Betta Pharmaceuticals's market cap has increased from 10.15B to 20.49B, an increase of 102.00%. That is a compound annual growth rate of 7.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 20.49B | 4.33% |
| Dec 31, 2025 | 19.64B | -12.96% |
| Dec 31, 2024 | 22.57B | 4.62% |
| Dec 29, 2023 | 21.57B | 5.11% |
| Dec 30, 2022 | 20.53B | -38.09% |
| Dec 31, 2021 | 33.15B | -25.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Walvax Biotechnology | 22.89B |
| Kangmei Pharmaceutical | 22.40B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 22.07B |
| Tasly Pharmaceutical Group | 21.87B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 21.43B |
| Jilin Aodong Pharmaceutical Group | 21.22B |
| Hybio Pharmaceutical | 20.63B |
| Chengdu Kanghong Pharmaceutical Group | 20.43B |